Globally, countries are rolling out Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) quarantine policies and vaccination programs. Research studies are needed in helping understand the likelihood of acquired immunity to reinfection and identify priority groups for vaccination to inform them. This study aimed to assess period prevalence and longitudinal changes in antibody levels after SARS-CoV-2 infection in Qatari primary care settings. A cohort study design with 2 data collection phases was undertaken-Phase 1 (conducted in July 2020) and Phase 2 (conducted in October 2020). A stratified random sampling technique by age, gender and nationality was utilized to identify the study sample. The total sample size required for the stu...
In Qatar, the first COVID-19 cases were reported on the 29th of February 2020, and the numbers incre...
peer reviewedAsymptomatic and pauci-symptomatic cases contribute to underestimating the prevalence o...
We sought to assess pre-vaccination and post-vaccination seroprevalences of anti-SARS-CoV-2 antibodi...
ABSTRACTBackgroundQatar has experienced a large SARS-CoV-2 epidemic. Our first objective was to asse...
The study objective was to the assess level of detectable severe acute respiratory syndrome coronavi...
Objectives: The primary objective is to determine the prevalence of SARS-CoV-2 antibodies persistenc...
BACKGROUND: Increased understanding of whether individuals who have recovered from COVID-19 are prot...
Background: Increased understanding of whether individuals who have recovered from COVID-19 are prot...
Summary: The study objective was to the assess level of detectable severe acute respiratory syndrome...
There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coron...
Background The prevalence and persistence of antibodies following a peak SARS-CoV-2 infection provid...
Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d after the onse...
BACKGROUND: Reinfection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has be...
Background There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syn...
The overarching objective of this study was to provide the descriptive epidemiology of the severe ac...
In Qatar, the first COVID-19 cases were reported on the 29th of February 2020, and the numbers incre...
peer reviewedAsymptomatic and pauci-symptomatic cases contribute to underestimating the prevalence o...
We sought to assess pre-vaccination and post-vaccination seroprevalences of anti-SARS-CoV-2 antibodi...
ABSTRACTBackgroundQatar has experienced a large SARS-CoV-2 epidemic. Our first objective was to asse...
The study objective was to the assess level of detectable severe acute respiratory syndrome coronavi...
Objectives: The primary objective is to determine the prevalence of SARS-CoV-2 antibodies persistenc...
BACKGROUND: Increased understanding of whether individuals who have recovered from COVID-19 are prot...
Background: Increased understanding of whether individuals who have recovered from COVID-19 are prot...
Summary: The study objective was to the assess level of detectable severe acute respiratory syndrome...
There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coron...
Background The prevalence and persistence of antibodies following a peak SARS-CoV-2 infection provid...
Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d after the onse...
BACKGROUND: Reinfection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has be...
Background There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syn...
The overarching objective of this study was to provide the descriptive epidemiology of the severe ac...
In Qatar, the first COVID-19 cases were reported on the 29th of February 2020, and the numbers incre...
peer reviewedAsymptomatic and pauci-symptomatic cases contribute to underestimating the prevalence o...
We sought to assess pre-vaccination and post-vaccination seroprevalences of anti-SARS-CoV-2 antibodi...